logo

ALPHATEC H(NSDQ:ATEC)
Alphatec is a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. Alphatec''s principal product offering is primarily focused on the estimated U.S. spine fusion market through its wholly-owned subsidiary, Alphatec Spine, Inc., and includes a variety of spinal implant products and systems comprised of components such as spine screws, spinal spacers, and plates that offer multiple solutions to address patients'' needs. In addition to Alphatec''s U.S. presence, it also participates in the Japanese spine fusion and orthopedic trauma markets through its subsidiary, Alphatec Pacific, Inc. Its mission is to be a value based leader in the spinal market by providing unmatched service to and taking scientific direction from our physician customers.
# Employees: 290
Address: 2051 Palomar Airport Road Suite 100,Carlsbad,CA,USA
Phone: 760-431-9286
Fax:
Website: www.alphatecmfg.com
Email:
Sector: Medical
Industry: MED/DENTAL-SUPP
Executive Officers
Mortimer Berkowitz III (Chmn.)
Dirk Kuyper (Presi.; C.E.O.)
John H. Foster (Dir.)
Steven M. Yasbek (C.F.O.; V.P. Treas.; Princ. Acctg. Off.)
Rohit M. Desai (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 3/8/2010
Mean EPS (Next Qtr): $0.00
Mean EPS (Year): ($0.22)
Mean Estimate(Long Term): $67.00
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 5
Shares Performance
Period ATEC Compare to S&P
YTD 82.55 % 51.07 %
4 Weeks -10.25 % -14.80 %
12 Weeks -4.24 % -10.83 %
Shares Information
Analyst Coverage: Y
Avg Volume: 156847
Shares Outstanding: 52M
Market Cap: $0.22B
52 Week High: $5.21
52 Week Low: $1.14
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 ATEC split by factor of 1.500
Earnings Performance
EPS Growth in Last Quarter: 84.62 %
EPS Growth in Last Year: 80.00 %
Sales Growth in Last Quarter: 1.28 %
Sales Growth in Last Quarter: 26.58 %
Financials
Qtr Book Value: $2.80
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: 1.810
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia